Recruiting NA Transversalis Fascia Plane Block

New treatment option for Transversalis Fascia Plane Block

Official title Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section

ClinicalTrials.gov ID: NCT07033104

What this study is testing

What it's testing
Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Adults, women only

You may be able to join if

  • female pt ASA2 scheduled for cs under spinal anesthesia

You likely can't join if

  • patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy

The study team makes the final eligibility decision.

Where it's taking place

  • Tanta, Gharbia Governorate, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, not specified. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Tanta, Gharbia Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.